Workflow
新 和 成(002001) - 2025年2月27日投资者关系活动记录表
002001NHU(002001)2025-02-27 10:29

Group 1: Company Overview and Financial Performance - The company aims to achieve a net profit of 5.8-6.2 billion CNY in 2024, representing a year-on-year growth of 114.48%-129.27% [2] - The net profit after deducting non-recurring gains is projected to be 5.7-6.12 billion CNY, with a growth of 118.04%-134.11% compared to the previous year [3] - The company has maintained a cash dividend policy since its listing, distributing 30%-50% of annual net profit as dividends, totaling 13.966 billion CNY in cumulative dividends [7] Group 2: Product Development and Market Expansion - The company has a production capacity of 300,000 tons/year for solid methionine and is collaborating with Sinopec on an 180,000 tons/year liquid methionine project [3] - The company is expanding its product lines in the nutritional segment, producing 8 out of 13 common vitamins, and is also involved in amino acids and colorants [3] - The PPS production capacity is currently 22,000 tons, with plans to expand to 30,000 tons based on market conditions [5] Group 3: Strategic Initiatives and Future Plans - The company is focusing on overseas market expansion, with over 50% of sales coming from international markets, primarily in the Americas, Europe, and Southeast Asia [6] - The company is investing in new projects, including the liquid methionine project and the nylon new materials project in Tianjin, which is currently under approval [5][7] - The company is committed to enhancing its innovation capabilities and has established research centers in Singapore and Japan to support overseas resource integration [7]